Pluri Inc. Form PRE 14A: Preliminary proxy statement
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2025-04-25: Form PRE 14A; Period of report 2025-05-23; Description PRELIMINARY PROXY STATEMENT; Document ea0239603-pre14a_pluriinc.htm.
- 2025-03-14: Form PRE 14A; Period of report 2025-05-14; Description PRELIMINARY PROXY STATEMENT; Document ea0234240-pre14a_pluriinc.htm.
- 2023-02-16: Form PRE 14A; Period of report 2023-02-16; Description PRELIMINARY PROXY STATEMENT; Document ea173793-pre14a_pluristem.htm.
- 2020-04-30: Form PRE 14A; Period of report 2020-04-30; Description PRELIMINARY PROXY STATEMENT; Document ea121146-pre14a_pluristem.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2025-04-25 | PRE 14A | 2025-05-23 | PRELIMINARY PROXY STATEMENT | ea0239603-pre14a_pluriinc.htm |
| 2025-03-14 | PRE 14A | 2025-05-14 | PRELIMINARY PROXY STATEMENT | ea0234240-pre14a_pluriinc.htm |
| 2023-02-16 | PRE 14A | 2023-02-16 | PRELIMINARY PROXY STATEMENT | ea173793-pre14a_pluristem.htm |
| 2020-04-30 | PRE 14A | 2020-04-30 | PRELIMINARY PROXY STATEMENT | ea121146-pre14a_pluristem.htm |
| 2019-04-15 | PRE 14A | 2019-04-15 | PRE 14A | zk1922918.htm |
| 2014-03-18 | PRE 14A | 2014-03-18 | PRE 14A | zk1414615.htm |
| 2009-11-10 | PRE 14A | 2009-11-10 | Preliminary proxy statement | zk97479.htm |
| 2008-05-20 | PRE 14A | 2008-05-20 | Preliminary proxy statement | zk85290.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |